Stock Events

Stock Events

Biotest 

0
0
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Jul 26
€0.04
Jul 25
€0.04
May 24
€0.04
May 22
€0.04
May 21
€0.04
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Carlisle Companies
CSL
Mkt Cap13.98B
CSL Limited is a global biotech leader that develops and delivers innovative biotherapies and influenza vaccines, directly competing with Biotest's plasma protein products and research in biotherapeutic areas.
Takeda Pharmaceutical
TAK
Mkt Cap58.92B
Takeda Pharmaceutical Company focuses on biopharmaceuticals, including plasma-derived therapies and vaccines, overlapping with Biotest's product range and therapeutic areas.
Grifols SA
GRFS
Mkt Cap5.31B
Grifols, S.A. specializes in plasma-derived medicinal products, making it a direct competitor to Biotest in the plasma therapy market.
Baxter International
BAX
Mkt Cap13.35B
Baxter International Inc. produces critical care, nutrition, renal, hospital, and surgical products, including biotherapies, competing in the same healthcare sectors as Biotest.
Pfizer
PFE
Mkt Cap162.16B
Pfizer Inc. is a broad-based pharmaceutical company that, among its wide range of products, develops vaccines and biotherapeutic products, competing with Biotest's research and product offerings.
Biogen
BIIB
Mkt Cap32.63B
Biogen Inc. focuses on neurology, rare diseases, and biologics, areas where Biotest also aims to make an impact, making them competitors in the biopharmaceutical field.
AMGEN
AMGN
Mkt Cap236.38B
Amgen Inc. is a biotechnology firm engaged in the discovery, development, and delivery of human therapeutics, competing with Biotest in the biotech and biotherapy space.
Gilead Sciences
GILD
Mkt Cap187.23B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet medical need, overlapping with Biotest's therapeutic areas.
Abbvie
ABBV
Mkt Cap453.19B
AbbVie Inc. is a research-driven biopharmaceutical company that develops and markets advanced therapies, competing with Biotest in the development of innovative treatments for various diseases.

About

BIOTEST GMBH & CO KGAA
Show more...
CEO
Jorg Schuttrumpf
Employees
2495
Country
Germany
ISIN
DE0005227235
WKN
000522723

Listings

LSE
GB
0N70.LSE
STU
DE
BIO.STU
STU
DE
BIO3.STU
OTC Link
US
BIESF

0 Comments

Share your thoughts

FAQ

What is Biotest stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Biotest stocks are traded under the ticker BIO3.STU.
Does Biotest pay dividends?▼
Yes, BIO3.STU dividends are paid annual. The last dividend per share was 0.04 EUR. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Biotest have?▼
As of September 08, 2026, the company has 2,495 employees.
In which sector is Biotest located?▼
Biotest operates in the Health & Wellness sector.
When did Biotest complete a stock split?▼
The last stock split for Biotest was on July 15, 2015 with a ratio of 3:1.
Where is Biotest headquartered?▼
Biotest is headquartered in Dreieich, Germany.